Ind-Swift Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Ind-Swift Laboratories Ltd. on BSE

Search Inside the pdf :

Ind-Swift Laboratories Ltd.

25 Aug 2025, 06:49PM

97.02

-0.98%

Company Update

Ind-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Allotment of 81,24,698 equity shares by the company pursuant to Scheme of Arrangement for the Amalgamation of Ind Swift Limited with Ind Swift Laboratories Limited.

pdf

Ind-Swift Laboratories Ltd.

25 Aug 2025, 06:45PM

97.02

-0.98%

Corp. Note

Ind-Swift Laboratories Ltd - 532305 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Please refer attached pdf.

pdf

Ind-Swift Laboratories Ltd.

14 Aug 2025

97.02

-0.98%

Company Update

Ind-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Please find enclosed MA report issued by CARE Ratings Limited for the quarter ended June 30, 2025.

pdf

Ind-Swift Laboratories Ltd.

13 Aug 2025

97.02

-0.98%

Result

Ind-Swift Laboratories Ltd - 532305 - Standalone And Consolidated Un-Audited Financial Results Of Ind-Swift Laboratories Limited …

BSE India

Please refer attached pdf

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	167.32	142.70	44.31	17.3%	277.6%
Operating Profit Qtr	3.60	-9.20	-9.74	139.1%	137.0%
Net Profit Qtr	8.77	222.27	0.94	-96.1%	833.0%
Earning Per Share Adjusted latest Qtr	1.19	30.25	0.13	-96.1%	815.4%

* Consolidated data

Detailed Results

Ind-Swift Laboratories Ltd.

13 Aug 2025

97.02

-0.98%

Board Meeting

Ind-Swift Laboratories Ltd - 532305 - Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON …

BSE India

The Board of Directors of the Company at its Meeting held today i.e., Wednesday, 13th August, 2025, have considered and inter-alia approved Standalone and Consolidated Un-Audited Financial Results for the quarter ended 30 June, 2025

pdf

Ind-Swift Laboratories Ltd.

11 Aug 2025

97.02

-0.98%

Result

Ind-Swift Laboratories Ltd - 532305 - Results-Delay in Financial Results

BSE India

Please find enclosed audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	167.32	142.70	44.31	17.3%	277.6%
Operating Profit Qtr	3.60	-9.20	-9.74	139.1%	137.0%
Net Profit Qtr	8.77	222.27	0.94	-96.1%	833.0%
Earning Per Share Adjusted latest Qtr	1.19	30.25	0.13	-96.1%	815.4%

* Consolidated data

Detailed Results

Ind-Swift Laboratories Ltd.

11 Aug 2025

97.02

-0.98%

Board Meeting

Ind-Swift Laboratories Ltd - 532305 - Board Meeting Outcome for Outcome Of Board Meeting Dated August …

BSE India

Outcome of Board Meeting dated August 11, 2025

pdf

Ind-Swift Laboratories Ltd.

08 Aug 2025

97.02

-0.98%

Company Update

Ind-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

Please find enclosed disclosure regarding filing of Form INC-28

pdf

Ind-Swift Laboratories Ltd.

04 Aug 2025

97.02

-0.98%

Company Update

Ind-Swift Laboratories Ltd - 532305 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Please refer attached pdf.

pdf

Ind-Swift Laboratories Ltd.

02 Aug 2025

97.02

-0.98%

Board Meeting

Ind-Swift Laboratories Ltd - 532305 - Board Meeting Intimation for Consideration And Approval Of Standalone And …

BSE India

Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter ended 30th June, 2025.

pdf

Is Ind-Swift Laboratories Ltd. worth buying?

90 Votes:

Buy 75.56%

Sell 13.33%

Hold 11.11%